Theravance Biopharma, Inc. (TBPH) has 46 open-market insider trades by 19 insiders since 2015. Over the last six months insiders net sold $5.8M. The most active filer is Bradford J. Shafer, VP & Secretary.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Glaxosmithkline PLC | 10% Owner | — | 1 | $30.0M | 2016-03-14 |
| Eli Samaha | 10% Owner | — | 3 | $26.7M | 2026-07-01 |
| Bradford J. Shafer | VPSecretary | — | 9 | $8.0M | 2021-08-20 |
| Renee D. Gala | CFOVP | — | 3 | $2.7M | 2018-11-20 |
| Brett K. Haumann | — | — | 6 | $2.1M | 2021-02-20 |
| Rick E. Winningham | CEO | — | 3 | $1.8M | 2026-08-20 |
| Philip D. Worboys | VP | — | 4 | $925K | 2021-11-19 |
| Andrew A. Hindman | CFOVP | — | 1 | $716K | 2022-11-20 |
| Burton G. Malkiel | Dir | — | 3 | $521K | 2023-05-02 |
| Richard A. Graham | VP | — | 4 | $481K | 2024-02-20 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Rhonda Farnum | VP | Sell | $227K | 2026-09-15 |
| Eli Samaha | 10% Owner | Sell | $5.8M | 2026-06-29 |
| Rhonda Farnum | VP | Sell | $218K | 2026-06-15 |
| Rhonda Farnum | VP | Sell | $650K | 2026-03-16 |
| Rhonda Farnum | VP | Sell | $1.2M | 2025-12-03 |
| Eran Broshy | Director | Sell | $590K | 2025-11-26 |
Companies that share insiders with TBPH, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Eran Broshy | Director | Sell | $287K | 2025-11-11 |
| Rhonda Farnum | VP | Sell | $174K | 2025-07-14 |
| Rhonda Farnum | VP | Sell | $264K | 2025-06-02 |
| Rhonda Farnum | SVP & COMM & MEDICAL AFFAIRS | Sell | $36K | 2025-04-21 |
| Rhonda Farnum | SVP & COMM & MEDICAL AFFAIRS | Sell | $36K | 2025-01-21 |
| Rhonda Farnum | SVP & COMM & MEDICAL AFFAIRS | Sell | $36K | 2024-11-11 |
| Eli Samaha | 10% Owner | Buy | $7.8M | 2024-08-07 |
| Rhonda Farnum | SVP & COMM & MEDICAL AFFAIRS | Sell | $36K | 2024-07-10 |
| Eli Samaha | 10% Owner | Buy | $13.1M | 2024-05-01 |